[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370132-105":59,"doc-detail-370132-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","an-overview-of-clinical-trials-in-anal-cancer-1999-2024","An overview of clinical trials in anal cancer 1999-2024","","Anal cancer is an uncommon malignancy, and progress in prevention and treatment depends on clinical trials despite substantial research challenges. This overview compiles registered clinical trials from major international trial registries between 1999 and 2024, categorizing studies by cancer stage and extent (pre-cancerous, early localized/curable, and advanced metastatic/likely incurable). Results summarize trial counts, phase distribution, geographic participation, recruiting status, and underrepresented groups, concluding that trial growth continues but disparities persist, especially limited activity in low-income countries and reliance on academic consortia.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-overview-of-clinical-trials-in-anal-cancer-1999-2024/370132/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-overview-of-clinical-trials-in-anal-cancer-1999-2024/370132.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are clinical trials important for anal cancer?","Question",{"text":112,"@type":113},"Clinical trials are crucial for improving prevention and treatment, but conducting well-powered studies is challenging in this condition.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the anal cancer trials categorized in this overview?",{"text":117,"@type":113},"Trials were grouped by context and disease extent into pre-anal cancer (pre-cancerous states), early anal cancer (localized, curable disease), and advanced anal cancer (metastatic and/or incurable disease).",{"name":119,"@type":110,"acceptedAnswer":120},"What disparities were identified in where trials were conducted?",{"text":121,"@type":113},"Most trials were conducted in high-income countries, multinational trials were limited, and immunosuppressed patients were underrepresented, with few trials in low-income countries.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370132,1790230817,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","ORIGINAL ARTICLE  \nAn overview of clinical trials in anal cancer 1999-2024  \nD. Verschoor1􀀁, E. S. L. Pedersen1, A. Tardit1 & E. Segelov1 , 2  \n1Department of Clinical Research, University of Bern, Bern; 2Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland  \nAvailable online 17 February 2025  \nBackground: Anal cancer (AC) is an uncommon malignancy. Clinical trials are crucial for improving prevention and treatment, but conducting research is challenging in this condition. This paper provides an overview of registered clinical trials in the prevention and treatment of AC between 1999 and 2024 .  \nMaterials and methods: AC trials were identiﬁed from the two main global trial databases: the International Clinical Trials Registry Platform and [clinicaltrials.gov](clinicaltrials.gov. Trials)[. Trials](clinicaltrials.gov. Trials) were categorized based on context and disease extent: pre-AC (pre-cancerous states), early AC (localized, curable disease), and advanced AC (metastatic and/or incurable disease) . Results: There were 251 trials identiﬁed: 55 pre-AC, 100 early AC, and 96 advanced AC. Only 10% were phase III studies. The number of trials increased over the 25-year period, particularly advanced AC trials since 2015 . Trials listed as active totaled 109, of which 54% were actively recruiting. Most trials were conducted in high-income countries and only 38 were multinational. Underrepresented groups were immunosuppressed patients. Only one-third of trials were industrysponsored, lower than most other cancer types.  \nConclusions: Although there has been a steady increase in AC trials, many research questions remain. Disparities are clear, with few trials in low-income countries, where the burden of disease is likely to grow as a consequence of less access to human papillomavirus (HPV) vaccination, which is likely to prevent disease. Clinical trials in AC rely mainly on academic consortia.  \nKey words: anal cancer, anal squamous-cell carcinoma, RCT, trials, international, HPV  \nINTRODUCTION  \nAnal cancer (AC) is an uncommon neoplasm affecting the mucosa-lined anal canal and less commonly the perianal skin.1 The most frequent histology is squamous-cell carcinoma (SCC), accounting for 75%-95% of cases, with the remainder adenocarcinoma (5%-15%) and very rare tumors including melanoma, neuroendocrine cancers, and metastases.2,3 Human papillomavirus (HPV) is estimated to cause up to 90% of anal SCC and the impact of HPV vaccination on prevention should be profound. AC usually presents as local or locoregional disease; metastatic disease is rare.4 AC incidence differs between population groups, being higher in females,4-6 older age, persons who have anal receptive intercourse,7-9 immunosuppression [especially people living with human immunodeﬁciency virus (HIV) and solid organ transplant recipients],7, 10-13 previous HPV-related cancers,14 and those with precursor lesions such as high-grade anal  \n*Correspondence to: Dr Daniëlle Verschoor, Department of Clinical Research, University of Bern, Freiburgstrasse 3, 3010 Bern, Switzerland. Tel: þ41-31-684- 59-36  \nE-mail: danielle.verschoor@unibe.ch (D. Verschoor) .  \n2949-8198/© 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CC BY license ([http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)).  \nintraepithelial neoplasm (AIN) .7,9, 13, 15, 16 Anal SCC incidence has increased over the past decades,2, 17 mainly in highincome countries (HIC), noting that little incidence data are available from low- and middle-income countries (LMIC) .  \nManagement of anal SCC has signiﬁcantly changed since landmark clinical trials almost 40 years ago demonstrated that outcomes from concurrent chemoradiation were equivalent to the mutilating surgery of abdominoperineal resection, which removes fecal continence.18-21 Although","cbCaif33NZbuBR4q","https://ap.wps.com/l/cbCaif33NZbuBR4q","pdf",609433,"English","# Background\n# Materials and methods\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"Why are clinical trials important for anal cancer?\",\"answer\":\"Clinical trials are crucial for improving prevention and treatment, but conducting well-powered studies is challenging in this condition.\"},{\"question\":\"How were the anal cancer trials categorized in this overview?\",\"answer\":\"Trials were grouped by context and disease extent into pre-anal cancer (pre-cancerous states), early anal cancer (localized, curable disease), and advanced anal cancer (metastatic and/or incurable disease).\"},{\"question\":\"What disparities were identified in where trials were conducted?\",\"answer\":\"Most trials were conducted in high-income countries, multinational trials were limited, and immunosuppressed patients were underrepresented, with few trials in low-income countries.\"}]","An overview of clinical trials in anal cancer 1999-2024 | PDF",1790186968,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/580cb7efc05eb9c3fefccb06eb28a738.webp",983,1269,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb0469bda7c54c47421cabb108a73d6d.webp",982,1268,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9b66c803619dcc9ba38fc367343883a.webp",981,1266,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/055505f8ff6bb9299a8d14720c4b7d9e.webp",980,1265]